Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT01946373
What this trial is testing

T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma

Who this might be right for
Melanoma
Karolinska University Hospital 20
Not applicableAvailableNCT04853602
What this trial is testing

IFx-Hu2.0 Expanded Access Program

Who this might be right for
Cutaneous Melanoma, Stage IIICutaneous Melanoma, Stage IVMerkel Cell Carcinoma+1 more
TuHURA Biosciences, Inc.
Testing effectiveness (Phase 2)Study completedNCT00021164
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Melanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00602199
What this trial is testing

ABT-510 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Mayo Clinic 42
Testing effectiveness (Phase 2)Study completedNCT00080353
What this trial is testing

Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma

Who this might be right for
Melanoma
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Study completedNCT01248936
What this trial is testing

RO5185426 in Patients With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 374
Not applicableStudy completedNCT00928031
What this trial is testing

Long-term Data Collection for Subjects in MDX-010 Studies

Who this might be right for
Metastatic Melanoma
Bristol-Myers Squibb 160
Testing effectiveness (Phase 2)Study completedNCT01266603
What this trial is testing

High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 44
Early research (Phase 1)Ended earlyNCT02097225
What this trial is testing

Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
BRAF V600E Mutation PresentBRAF V600K Mutation PresentMetastatic Malignant Solid Neoplasm+7 more
National Cancer Institute (NCI) 22
Not applicableStudy completedNCT02332642
What this trial is testing

Immuno-monitoring of Patients With Metastatic Melanoma (AJCC Stadium IV) Under Chemotherapy

Who this might be right for
Immuno-monitoring
Universitätsmedizin Mannheim 12
Testing effectiveness (Phase 2)Study completedNCT03007823
What this trial is testing

High-activity Natural Killer Immunotherapy for Small Metastases of Melanoma

Who this might be right for
Melanoma
Fuda Cancer Hospital, Guangzhou 20
Early research (Phase 1)Ended earlyNCT01810016
What this trial is testing

NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Unresectable or Metastatic Melanoma
Ludwig Institute for Cancer Research 8
Testing effectiveness (Phase 2)Study completedNCT00005971
What this trial is testing

Flavopiridol in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Melanoma (Skin)
NCIC Clinical Trials Group 17
Testing effectiveness (Phase 2)Study completedNCT02259231
What this trial is testing

RTA 408 Capsules in Patients With Melanoma - REVEAL

Who this might be right for
MelanomaUnresectable (Stage III) MelanomaMetastatic (Stage IV) Melanoma
Biogen 41
Testing effectiveness (Phase 2)UnknownNCT00287131
What this trial is testing

Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients

Who this might be right for
Metastatic Melanoma
Sheba Medical Center 70
Testing effectiveness (Phase 2)UnknownNCT03374839
What this trial is testing

Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients

Who this might be right for
Melanoma
Nantes University Hospital 11
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00399113
What this trial is testing

Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Pain Therapeutics 12
Early research (Phase 1)UnknownNCT04142931
What this trial is testing

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

Who this might be right for
Stage IV Non-small Cell Lung CancerStage IV MelanomaTriple Negative Breast Cancer+1 more
Dr. Ronnie Shapira 30
Not applicableUnknownNCT06207747
What this trial is testing

Quantitative Analysis of PET/CT Images of Immune Related Side Effects in Metastatic Melanoma Patients

Who this might be right for
MelanomaPET CT
Institute of Oncology Ljubljana 70
Next Page